Yield10 Bioscience to Participate in the Benzinga Global Small Cap Conference on December 9, 2021
WOBURN, Mass., Dec. 06, 2021 (GLOBE NEWSWIRE) — Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, announced today that management will participate at the Benzinga Global Small Cap Conference on December 9, 2021.
President and Chief Executive Officer Oliver Peoples, Ph.D. will deliver his presentation at 10:30 AM EST on Thursday, December 9, 2021. Dr. Peoples will also be available to participate in one-on-one meetings with investors who are registered to attend the conference. An archived replay of the presentation will be available via the conference website.
Investors can register for the conference here:
https://www.benzinga.com/events/small-cap/december-2021-global/
About Yield10 Bioscience
Yield10 Bioscience, Inc. is an agricultural bioscience company that is using its differentiated trait gene discovery platform, the “Trait Factory”, to develop improved Camelina varieties for the production of proprietary seed products, and to discover high value genetic traits for the agriculture and food industries. Our goals are to efficiently establish a high value seed products business based on developing superior varieties of Camelina for the production of feedstock oils, nutritional oils, and PHA bioplastics, and to license our yield traits to major seed companies for commercialization in major row crops, including corn, soybean and canola. Yield10 is headquartered in Woburn, MA and has an Oilseeds Center of Excellence in Saskatoon, Canada.
For more information about the company, please visit www.yield10bio.com, or follow the Company on Twitter, Facebook and LinkedIn.
Contacts:
Yield10 Bioscience:
Lynne H. Brum, (617) 682-4693, LBrum@yield10bio.com
Investor Relations:
Bret Shapiro, (561) 479-8566, brets@coreir.com
Managing Director, CORE IR
Media Inquiries:
Eric Fischgrund, eric@fischtankpr.com
FischTank PR
